Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Persistence with stroke prevention medications 3 months after hospitalization.

Bushnell CD, Zimmer LO, Pan W, Olson DM, Zhao X, Meteleva T, Schwamm L, Ovbiagele B, Williams L, Labresh KA, Peterson ED; Adherence Evaluation After Ischemic Stroke–Longitudinal Investigators.

Arch Neurol. 2010 Dec;67(12):1456-63. doi: 10.1001/archneurol.2010.190. Epub 2010 Aug 9.

PMID:
20697032
2.

In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.

Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B.

J Stroke Cerebrovasc Dis. 2008 Jan-Feb;17(1):5-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.09.004.

PMID:
18190814
3.

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics.

Bushnell C, Zimmer L, Schwamm L, Goldstein LB, Clapp-Channing N, Harding T, Drew L, Zhao X, Peterson E; AVAIL registry.

Am Heart J. 2009 Mar;157(3):428-435.e2. doi: 10.1016/j.ahj.2008.11.002.

PMID:
19249411
4.

Comprehensive cardiac rehabilitation for secondary prevention after transient ischemic attack or mild stroke: I: feasibility and risk factors.

Prior PL, Hachinski V, Unsworth K, Chan R, Mytka S, O'Callaghan C, Suskin N.

Stroke. 2011 Nov;42(11):3207-13. doi: 10.1161/STROKEAHA.111.620187. Epub 2011 Sep 22.

5.

Secondary preventive medication persistence and adherence 1 year after stroke.

Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, Kidwell C, Labresh KA, Ovbiagele B, Schwamm L, Peterson ED; AVAIL Investigators.

Neurology. 2011 Sep 20;77(12):1182-90. doi: 10.1212/WNL.0b013e31822f0423. Epub 2011 Sep 7.

6.

Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry.

Ji R, Liu G, Shen H, Wang Y, Li H, Peterson E, Wang Y.

Neurol Res. 2013 Jan;35(1):29-36. doi: 10.1179/1743132812Y.0000000107.

PMID:
23317796
7.

Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack.

Scott DP, Greenfield JR, Bramah V, Alford J, Bennett C, Markus R, Campbell LV.

Intern Med J. 2010 Apr;40(4):275-80. doi: 10.1111/j.1445-5994.2009.01941.x. Epub 2009 Mar 9.

PMID:
19383060
8.

Secondary prevention of stroke.

MacDougall NJ, Amarasinghe S, Muir KW.

Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1103-15. doi: 10.1586/erc.09.77. Review.

PMID:
19764863
9.

In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up.

Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS.

Stroke. 2004 Dec;35(12):2879-83. Epub 2004 Oct 28.

10.

Similar secondary stroke prevention and medication persistence rates among rural and urban patients.

Rodriguez D, Cox M, Zimmer LO, Olson DM, Goldstein LB, Drew L, Peterson ED, Bushnell CD; AVAIL Investigators.

J Rural Health. 2011 Winter;27(4):401-8. doi: 10.1111/j.1748-0361.2010.00352.x. Epub 2011 Jan 4.

PMID:
21967384
11.

[A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].

Ma RH, Wang YJ, Wang CX, Zhao XQ, Wang YL, Xu MJ, Wei M, Li Y, Zhang Z, Zhang WW, Wang L, Lin L, Li HT, Zheng T, Wang XW, Li JJ, Lü Y, Qi D.

Zhonghua Yi Xue Za Zhi. 2008 Oct 14;88(37):2618-22. Chinese.

PMID:
19080709
12.

Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.

Van Schaik SM, Van den Berg-Vos RM, Weinstein HC, Bosboom WM.

J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1378-82. doi: 10.1016/j.jstrokecerebrovasdis.2015.02.023. Epub 2015 Mar 21.

PMID:
25804570
13.

Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event.

Ovbiagele B, Hills NK, Saver JL, Johnston SC.

Stroke. 2005 Sep;36(9):1944-7. Epub 2005 Jul 28.

14.

Impact of enhanced secondary prevention on health behaviour in patients following minor stroke and transient ischaemic attack: a randomized controlled trial.

Gillham S, Endacott R.

Clin Rehabil. 2010 Sep;24(9):822-30. doi: 10.1177/0269215510367970. Epub 2010 Aug 4.

PMID:
20685723
15.

An evaluation of stroke education in AVAIL registry hospitals.

West A, Cox M, Zimmer LO, Fedder W, Weber C, Drew L, Peterson ED, Bushnell C, Olson DM.

J Neurosci Nurs. 2012 Jun;44(3):115-23. doi: 10.1097/JNN.0b013e3182510657.

PMID:
22555348
16.

Carotid artery imaging for secondary stroke prevention: both imaging modality and rapid access to imaging are important.

Wardlaw JM, Stevenson MD, Chappell F, Rothwell PM, Gillard J, Young G, Thomas SM, Roditi G, Gough MJ.

Stroke. 2009 Nov;40(11):3511-7. doi: 10.1161/STROKEAHA.109.557017. Epub 2009 Sep 3.

17.

Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.

Tentschert S, Parigger S, Dorda V, Bittner K, Unterbuchschachner D, Greisenegger S, Wimmer R, Brücke T, Lang W, Lalouschek W; Vienna Stroke Study Group.

Wien Klin Wochenschr. 2004 Dec 30;116(24):834-8.

PMID:
15690967
18.

Secondary prevention of ischaemic stroke and TIA.

Diener HC.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):229. No abstract available.

19.

Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.

Lalouschek W, Lang W, Müllner M; Vienna Stroke Study Group.

Stroke. 2001 Dec 1;32(12):2860-6.

20.

Secondary prevention after minor stroke and TIA - usual care and development of a support program.

Leistner S, Benik S, Laumeier I, Ziegler A, Nieweler G, Nolte CH, Heuschmann PU, Audebert HJ.

PLoS One. 2012;7(12):e49985. doi: 10.1371/journal.pone.0049985. Epub 2012 Dec 17.

Items per page

Supplemental Content

Write to the Help Desk